Pharmally chair says documentation lapses ‘not intentional’

Pharmally Pharmaceutical Corp. chairman Huang Tzu Yen during the Senate blue ribbon committee hearing on Friday, Dec. 3, 2021. Senate screengrab

MANILA, Philippines — The Singapore-based chairman of Pharmally Pharmaceutical Corp. on Friday apologized to senators for not being hands-on with the firm’s documentation but denied that its failure to properly organize its financial records was intentional.

During the resumption of the Senate blue ribbon committee’s investigation, senators prodded Pharmally officials regarding the whereabouts of its financial documents earlier subpoenaed by the panel.

“I know it is no excuse, as a company, it is no excuse to not have these things properly documented and filed and on-hand and ready. But it is not intentional. I don’t think it is intentional,” Pharmally chairman Huang Tzu Yen told senators.

The failure to turn over these records to the panel in the past weeks led to the transfer of Pharmally executives Mohit Dargani and Linconn Ong to a city jail and the detention of Pharmally acting president Twinkle Dargani in the Senate compound.

All three of them insisted on not knowing the location of the documents.

“I do not have most of the copies of the cost of goods sold cause I’m overseas and I wasn’t hands-on with this and I apologize for that. But I think for many of the deliveries we make, I think I did request for these pictures, some photos of deliveries,” Huang, who is currently in Singapore, said.

“I would compile those but in terms of document-wise I will try but I really do not have a lot of those, I apologize,” he added.

Pharmally has been at the center of the blue ribbon’s investigation into the government’s medical supply purchases at the height of the pandemic last year.

The firm was able to secure over P8.6 billion worth of supply contracts in 2020 despite being incorporated only several months prior with a P625,000 paid-up capital.


BIR audits tax compliance of Pharmally 


Subscribe to our daily newsletter

Success! You have been subscribed!
Oops! Something went wrong and you could not be subscribed

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.